WFG Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

WFG Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$0	Hold	1	–	–	﹤0.01%	1678
2017 Q1	$0	Hold	1	–	–	﹤0.01%	1675
2016 Q4	$0	Sell	1 -20	-95%	-$1.63K	﹤0.01%	1743
2016 Q3	$2K	Hold	21	–	–	﹤0.01%	1414
2016 Q2	$2K	Hold	21	–	–	﹤0.01%	1394
2016 Q1	$2K	Buy	21 +1	+5%	+$90	﹤0.01%	1358
2015 Q4	$3K	Hold	20	–	–	﹤0.01%	1319
2015 Q3	$2K	Hold	20	–	–	﹤0.01%	1438
2015 Q2	$2K	Hold	20	–	–	﹤0.01%	1504
2015 Q1	$2K	Hold	20	–	–	﹤0.01%	1573
2014 Q4	$2K	Hold	20	–	–	﹤0.01%	1882
2014 Q3	$2K	Hold	20	–	–	﹤0.01%	1903
2014 Q2	$2K	Hold	20	–	–	﹤0.01%	1845
2014 Q1	$1K	Hold	20	–	–	﹤0.01%	1920
2013 Q4	$1K	Hold	20	–	–	﹤0.01%	2133
2013 Q3	$2K	Hold	20	–	–	﹤0.01%	1960
2013 Q2	$2K	Buy	+20	New	+$1.47K	﹤0.01%	1872

Other funds holding VRTX

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return